Studying blood and clot cells in stroke patients
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at blood and clot samples from people who have had a stroke to understand how inflammatory cells behave. It may help doctors learn more about why strokes happen and improve treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are in the emergency room with signs of a stroke, stroke-like symptoms, or risk factors for stroke
- You are being treated with one of these: mechanical thrombectomy (clot removal), IV thrombolysis (clot-busting drug), or standard medical therapy
- You agree to participate (or a legal representative agrees for you)
- You are not pregnant or breastfeeding
- You do not have an autoimmune disease that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the composition of a stroke blood clot and compares it with blood test results to understand treatment response, stroke cause, and prognosis. It may help doctors better predict outcomes and improve care after ischemic stroke.
This study includes people who have had certain kinds of sudden brain blood-flow problems (like an ischemic stroke, bleeding in the brain, or a brief warning episode) or conditions that look similar. It looks at how treatment such as clot-busting medicine (thrombolysis) fits for these situations.
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
This study looks at blood markers of inflammation in people who have a stroke caused by a blocked vessel and then have a procedure to remove the clot. It aims to see if these markers can predict how well people recover.
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
This study looks at how blood clots and inflammation interact after a stroke or bleeding in the brain to find new ways to treat these emergencies. If you join, researchers will study your blood to understand these processes, which may lead to better future treatments.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.